Article info

Download PDFPDF
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis

Authors

  • David Simon Department of Internal Medicine 3- Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Filippo Fagni Department of Internal Medicine 3- Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3- Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, Erlangen, GermanyDeutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Georg Schett, Rheumatology, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany; georg.schett{at}uk-erlangen.de
View Full Text

Citation

Simon D, Fagni F, Schett G
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis

Publication history

  • Received March 15, 2022
  • Accepted April 25, 2022
  • First published May 5, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.